Abstract
Calcium antagonists (CA) exert an anti-atherosclerotic effect in cholesterol-fed rabbits through reduction of cholesterol accumulation in the arterial wall. Further studies in our Institute indicate that verapamil-like compounds and diltiazem stimulate receptor-mediated LDL uptake by human fibroblasts in culture, while nifedipine-like compounds and flunarizine are inactive. Verapamil and diltiazem stimulated LDL-receptor activity also in cells from a heterozygous FH patient, while they were inactive in a receptor defective homozygous FH patient. A basic group needs to be present on the CA molecule to modulate the LDL receptor expression. Preliminary data in our laboratory suggest that some CA can achieve concentrations in the aortic wall likely to exert effects on LDL receptors. This stimulatory activity may improve lipid metabolism in the arterial wall.
Similar content being viewed by others
References
BerniniF.,FantoniM.,CorsiniA. andFumagalliR. (1990): “In vitro” inhibition of arterial myocytes growth and stimulation of low density lipoprotein metabolism by SIM 6080, a new calcium antagonist - Pharmacological Res.22: 27–35.
Bertulli S.M., Bellosta S., Fantoni M., Corsini A., Fumagalli R. andBernini F. (1989): Antiatherosclerotic effect of the new calcium antagonist SIM 6080 - In: Atherosclerosis and Cardiovalscular Disease - Descivich G.C., Gaddi A., Magri G.L. and Lenzi S. - Eds. Bologna Editrice Compositori vol. 4: 819–924.
DaughertyA.,RatedD.L.,SchonfeldG. andSobelB.E. (1987): Inhibition of cholesteryl ester deposition in macrophages by calcium entry blockers: an effect dissociable from calcium entry blockade - Br. J. Pharmacol.91: 113–8.
Paoletti R., Bernini F., Fumagalli R., Allorio M. andCorsini A. (1988): Calcium antagonists and low density lipoprotein receptors - In: “Calcium antagonists. Pharmacology and Clinical Research” - Vanhoutte P.M., Paoletti R. and Govoni S. - Eds. Ann. NY Acad. Sci. 522: 390–398.
PaolettiR. andBerniniF. (1990): A new generation of calcium antagonists and their role in atherosclerosis -Am. J. Cardiol.66: 2811–3111.
ParmleyW.W. (1987): Calcium channel blockers and atherogenesis - Am. J. Med.82 (suppl. 313): 3–8.
RanganathanS. andJacksonR.L. (1984): Effect of calcium channel-blocking drugs on lysosomal function in human skin fibroblasts - Biochem. Pharmacol.33 (15): 2377–2382.
RossR. (1986): The pathogenesis of atherosclerosisan update - New Engl. J. Med.314: 488–500.
SteinO.,LeitersdorfE. andSteinY. (1985): Verapamil enhances receptor mediated endocytosis of LDL by aortic cells in culture - Arteriosclerosis5: 35–44.
WeinsteinD.B. andHeiderJ.G. (1987): Antiatherogenic properties of calcium antagonists -Am. J. Cardiol.59: 16313–17213.
Author information
Authors and Affiliations
Additional information
Corresponding author
Rights and permissions
About this article
Cite this article
Bernini, F., Paoletti, R. Focus on anti-atherosclerotic therapy. Eur J Epidemiol 8 (Suppl 1), 104–106 (1992). https://doi.org/10.1007/BF00145360
Issue Date:
DOI: https://doi.org/10.1007/BF00145360